Hospital Medicine

Resource Center

Clinical Insights

Bacterial Infections

Joseph Solomkin, MD, on the Results From the IGNITE4 Trial

10/18/2016

He answers our questions about the IGNITE4 trial, which evaluated eravacycline vs meropenem for the treatment of intra-abdominal infections among acutely hospitalized patients.

10/18/2016

Hospital Medicine

Recommendations for Treating Patients With Diabetes in the Hospital Setting

12/17/2014

Steven Edelman, MD, and Kristen Kulasa, MD, discuss the current recommendations for treating patients with diabetes in the inpatient setting.

12/17/2014

Research Summaries

Research summary

Hospitalized Adults Inappropriately Diagnosed With Community-Acquired Pneumonia Is Common

07/10/2024

A team of researchers sought to determine the incidence of inappropriate diagnosis among patients hospitalized and treated for community-acquired pneumonia.

07/10/2024

COVID-19 ROUNDUP

Elevated Risks for Patients Hospitalized With COVID-19 at 3 Years, Worldwide Overuse of Antibiotics, Perinatal Health Among Birth Mothers With SARS-CoV-2 Infection, and More

06/07/2024

Anthony Calabro, MA

In this COVID-19 roundup, researchers report on the risk of health issues and death among patients hospitalized with COVID-19 at 3 year-follow-up, the widespread overuse of antibiotics among patients with...

06/07/2024

COVID-19 Roundup

Record Low COVID-19 Hospitalizations, Metformin Reduces SARS-Cov-2 Viral Load, Low Mortality Rates in Older Patients Taking Remdesivir, and More

05/21/2024

Anthony Calabro, MA

In this COVID-19 roundup, the CDC reports a record low number of COVID-19 hospitalizations, metformin reduces the likelihood of SARS-CoV-2 Viral load and rebound, remdesivir reduces mortality in older...

05/21/2024

Research Summary

Comparison of Cefepime and Piperacillin-Tazobactam For Risk of Acute Kidney Injury

01/09/2024

Jessica Ganga

In a randomized clinical trial, a team of researchers compared the use of cefepime and piperacillin-tazobactam—commonly used medications for empirical treatment of infection—to determine the risks of...

01/09/2024

FDA alert

New Treatment for Certain Bacterial Pneumonia Approved by FDA

08/25/2023

Jessica Ganga

Following a multicenter clinical trial, a new treatment for pneumonia caused by Acinetobacter baumannii-calcoaceticus has been approved for use in adults.

08/25/2023

September 2024

Current Issue

September 2024

Volume 64

Issue 9